UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chemotherapieinduzierte Nausea und Emesis

HNO, 2023-07, Vol.71 (7), p.473-484

Karthaus, Meinolf

2023

Volltextzugriff (PDF)

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

The Lancet (British edition), 2016-02, Vol.387 (10020), p.760-769

2016

Volltextzugriff (PDF)

Invasive aspergillosis: new insights into disease, diagnostic and treatment

Current pharmaceutical design, 2013-06, Vol.19 (20), p.3569-3594

2013

Volltextzugriff (PDF)

Chemotherapy-induced nausea and vomiting

HNO, 2023-07, Vol.71 (7), p.473-484

Karthaus, Meinolf

2023

Volltextzugriff (PDF)

Chemotherapieinduzierte Nausea und Emesis

Best practice onkologie, 2023-04, Vol.18 (4), p.166-176

Karthaus, Meinolf

2023

Volltextzugriff (PDF)

Netupitant-palonosetron (NEPA) for Preventing Chemotherapy-induced Nausea and Vomiting: From Clinical Trials to Daily Practice

Current cancer drug targets, 2022-01, Vol.22 (10), p.806-824

2022

Volltextzugriff (PDF)

Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

Annals of hematology, 2021-02, Vol.100 (2), p.321-336

2021

Volltextzugriff (PDF)

Phase II Study of the Dual EGFR/HER3 Inhibitor Duligotuzumab (MEHD7945A) versus Cetuximab in Combination with FOLFIRI in Second-Line RAS Wild-Type Metastatic Colorectal Cancer

Clinical cancer research, 2018-05, Vol.24 (10), p.2276-2284

2018

Volltextzugriff (PDF)

Subgroup analyses from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial

BMC cancer, 2024-07, Vol.24 (1), p.887-11, Article 887

2024

Volltextzugriff (PDF)

Chemotherapy-induced nausea and vomiting

HNO, 2023-07, Vol.71 (7), p.473

Karthaus, Meinolf

2023

Volltextzugriff (PDF)

Safety profile of trifluridine/tipiracil monotherapy in clinical practice: results of the German compassionate-use program for patients with metastatic colorectal cancer

BMC cancer, 2018-11, Vol.18 (1), p.1124-8, Article 1124

2018

Volltextzugriff (PDF)

Review of oral fixed-dose combination netupitant and palonosetron (NEPA) for the treatment of chemotherapy-induced nausea and vomiting

Future oncology (London, England), 2015-02, Vol.11 (4), p.565-577

2015

Volltextzugriff (PDF)

PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer

Journal for immunotherapy of cancer, 2021-07, Vol.9 (7), p.e002844

2021

Volltextzugriff (PDF)

Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology

Haematologica (Roma), 2009-01, Vol.94 (1), p.113-122

2009

Volltextzugriff (PDF)

Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy

Mycoses, 2011-07, Vol.54 (4), p.279-310

2011

Volltextzugriff (PDF)

Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors

Clinical colorectal cancer, 2015-12, Vol.14 (4), p.281-290

2015

Volltextzugriff (PDF)

Fixed combination of oral NEPA (netupitant‐palonosetron) for the prevention of acute and delayed chemotherapy‐induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: Efficacy data from 2 randomized, double‐blind phase III studies

Cancer medicine (Malden, MA), 2019-05, Vol.8 (5), p.2064-2073

2019

Volltextzugriff (PDF)

Treatment of invasive fungal infections in cancer patients--Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Annals of hematology, 2009-02, Vol.88 (2), p.97-110

2009

Volltextzugriff (PDF)

Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial

The Lancet. Healthy longevity, 2022-06, Vol.3 (6), p.e417-e427

2022

Volltextzugriff (PDF)

Impact of Primary Tumour Location and Early Tumour Shrinkage on Outcomes in Patients with RAS Wild-Type Metastatic Colorectal Cancer Following First-Line FOLFIRI Plus Panitumumab

Drugs in R&D, 2019-09, Vol.19 (3), p.267-275

2019

Volltextzugriff (PDF)

VELOUR trial biomarkers update: Impact of RAS, BRAF, and sidedness on aflibercept activity

Annals of oncology, 2017-06, Vol.28, p.iii151-iii152

2017

Volltextzugriff (PDF)

Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study

BMC cancer, 2012-09, Vol.12 (1), p.438-438, Article 438

2012

Volltextzugriff (PDF)

Supportive Care in Cancer Patients: Recent Developments

Karthaus, Ganser

1999

Volltextzugriff (PDF)

1 – 25 von 205

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(199)
Mit Volltextzugriff
(188)

Publikationsform

Artikel
(202)
Bücher
(2)
Texte
(1)

Sprache

Englisch
(178)
Deutsch
(28)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(106)
Science & Technology
(106)
Humans
(101)
Oncology
(60)
Female
(43)
Male
(43)
Middle Aged
(40)
Adult
(36)
Aged
(33)
Hematology
(29)
Chemotherapy
(28)
Antifungal Agents - Therapeutic Use
(27)
Colorectal Neoplasms - Drug Therapy
(23)
Aged, 80 And Over
(21)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(21)
Clinical Trials
(21)
Medicine
(21)
Medicine & Public Health
(21)
Cancer
(20)
Colorectal Cancer
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Chemotherapieinduzierte Nausea und Emesis

Central venous catheter–related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Invasive aspergillosis: new insights into disease, diagnostic and treatment

Chemotherapy-induced nausea and vomiting

Chemotherapieinduzierte Nausea und Emesis

Netupitant-palonosetron (NEPA) for Preventing Chemotherapy-induced Nausea and Vomiting: From Clinical Trials to Daily Practice

Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

Phase II Study of the Dual EGFR/HER3 Inhibitor Duligotuzumab (MEHD7945A) versus Cetuximab in Combination with FOLFIRI in Second-Line RAS Wild-Type Metastatic Colorectal Cancer

Subgroup analyses from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial

Chemotherapy-induced nausea and vomiting

Safety profile of trifluridine/tipiracil monotherapy in clinical practice: results of the German compassionate-use program for patients with metastatic colorectal cancer

Translational analysis and final efficacy of the AVETUX trial - Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer

Review of oral fixed-dose combination netupitant and palonosetron (NEPA) for the treatment of chemotherapy-induced nausea and vomiting

PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer

Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology

Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy

Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors

Fixed combination of oral NEPA (netupitant‐palonosetron) for the prevention of acute and delayed chemotherapy‐induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: Efficacy data from 2 randomized, double‐blind phase III studies

Treatment of invasive fungal infections in cancer patients--Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial

Impact of Primary Tumour Location and Early Tumour Shrinkage on Outcomes in Patients with RAS Wild-Type Metastatic Colorectal Cancer Following First-Line FOLFIRI Plus Panitumumab

VELOUR trial biomarkers update: Impact of RAS, BRAF, and sidedness on aflibercept activity

Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study

Supportive Care in Cancer Patients: Recent Developments

Suchergebnisse filtern